Connect with us
The theory that SARS-CoV-2, the virus responsible for COVID-19, could have come from a Wuhan laboratory has once again resurfaced after a top Chinese scientist openly...
A global financial services group has revealed that air travel between China and the U.S. remains limited even in the post-pandemic era. Fewer than 6% of...
The tally of COVID-19 cases following a large gathering for a conference last month has climbed to 181 from the initial 35. The Centers for Disease...
We are now in the post-pandemic era after the World Health Organization (WHO) announced on May 5 that COVID-19 should no longer be considered a public...
China is no longer taking an economic pause and implementing lockdowns even if COVID-19 cases are on the rise in the country. About half a year...
The COVID-19 pandemic may be a thing of the past now, but the risk of catching the viral disease remains. And so, pharmaceutical companies are still...
The hesitancy to get the updated COVID-19 booster has put many adults in the U.S. in danger of catching the viral disease. The latest Morbidity and...
Pfizer’s antiviral drug for the treatment of COVID-19, Paxlovid, will remain free for now. The U.S. government will continue to distribute it at no charge despite...
The U.S. Food and Drug Administration (FDA) has officially approved the first oral antiviral Paxlovid for the treatment of COVID-19 in adults. The treatment combines nirmatrelvir...
It was only a matter of time until New York terminated its vaccine mandate for health workers after the World Health Organization (WHO) declared COVID-19 no...
Recent Comments